Project Details
Description
PROJECT SUMMARY/ABSTRACT
Insufficient T cell infiltration is a major challenge in adoptive transfer therapies like CAR-T. Therefore, one
strategy to improve therapy is to enhance T cell trafficking into tumors. However, current therapies targeting T
cell activities largely consist of immune checkpoint modulators, and very little innovation has occurred in
therapeutic design targeting T cell intrinsic regulators of intratumoral accumulation. This is due, in part, to an
incomplete understanding of the regulatory pathways involved in T cell trafficking. We recently identified Adapter
protein 2 associated kinase 1 (Aak1) as an important regulator of T cell chemotaxis into tumors in an in vivo
forward genetic screen. The primary objective of this project is to measure the translational potential of AAK1 as
a therapeutic target in cancer to augment adoptive transfer therapies, with the additional goal of better
understanding molecular functions of Aak1 as a regulator of chemokine receptor Cxcr3 internalization. These
goals will be accomplished in three aims. Aim 1 will quantify the impact of genetic modification of Aak1 on tumor
infiltration of adoptively transferred T cells in a preclinical solid tumor model. Aim 2 will determine whether Aak1
kinase activity is required for chemokine-induced internalization of Cxcr3 in primary T cells. Aim 3 will measure
the degree to which Aak1 modification impacts therapeutic efficacy in adoptive transfer therapies. This proposal
has several innovative aspects, including characterization of a novel, T cell specific Aak1 knockout mouse,
functional and mechanistic testing of a novel Aak1 mutant construct, and evaluation of Aak1 as a novel
therapeutic target to limit T cell chemotaxis into inflamed tissue. Successful completion of this project will benefit
development of novel treatment strategies for solid tumors, and findings can broadly be applied to any T cell
adoptive transfer approach and is not limited to individual CAR or TCR engineered platforms.
Status | Finished |
---|---|
Effective start/end date | 2/16/23 → 1/31/24 |
Funding
- National Cancer Institute: $457,635.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.